Диссертация (1173248), страница 14
Текст из файла (страница 14)
– Vol. 15. – P. 289–98.28.Brat, D. J. Vaso-occlusive and prothrombotic mechanisms associated withtumor hypoxia, necrosis, and accelerated growth in glioblastoma /, D. J. Brat, E. G.Van Meir // Laboratory Investigation; A Journal of Technical Methods andPathology. – 2004. – Vol. 84. – P. 397–405.29.Brex, P. A. Proton MR spectroscopy in clinically isolated syndromessuggestive of multiple sclerosis / P.
A. Brex, B. Gomez-Anson, G.J. Parker, et al. //J. Neurol. Sci. – 1999. - Vol. 166(1). – P. 16-22.9930.Bruhn, H. Noninvasive differentiation of tumors with use of localized H-1 MRspectroscopy in vivo: initial experience in patients with cerebral tumors / H. Bruhn,J. Frahm, M.L. Gyngell et al. // Radiology. – 1989. – Vol.
172(2). – P. 541–548.31.Bulakbasia, N. Combination of Single Voxel Proton MR Spectroscopy andApparent Diffusion Coefficient Calculation in the Evaluation of Common BrainTumors / N. Bulakbasia, M. Kocaoglua, F. Wrsa et al. // Am. J. Neuroradiol. - 2003.– Vol. 24. – P. 225–233.32.Burger, P. C Glioblastoma multiforme and anaplastic astrocytoma.
Pathologiccriteria and prognostic implications / P. C. Burger, F. S. Vogel, S. B. Green et al. //Cancer. – 1985. Vol. 56. – P. 1106–1111.33.Castillo, M Correlation of myo-inositol levels and grading of cerebralastrocytomas / M. Castillo, J. K. Smith, L. Kwock // AJNR: American Journal ofNeuroradiology. – 2000. Vol. 21. – P. 1645–1649.34.Chantal, S.
Correlation of regional proton magnetic resonance spectroscopicmetabolic changes with cognitive deficits in mild Alzheimer disease / S. Chantal,M. Labelle, R. W. Bouchard et al. // Arch Neurol. – 2002. Vol. 59(6). – P. 955–962.35.Chawla, S. Arterial spin-labeling and MR spectroscopy in the differentiationof gliomas / S.
Chawla, S. Wang, R. L. Wolf et al. // AJNR Am J Neuroradiol.– 2007. Vol. 28(9). – P. 1683–1689.36.Chernov,M.F.Spectroscopy-supportedframe-basedimage-guidedstereotactic biopsy of parenchymal brain lesions: comparative evaluation ofdiagnostic yield and diagnostic accuracy / M. F. Chernov, Y. Muragaki, T. Ochiai etal. // Clinical Neurology and Neurosurgery.
– 2009. – Vol. 111. – P. 527–35.37.Chiang, I. C. Distinction between high-grade gliomas and solitary metastasesusing peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusionimagings / I. C Chiang, Y. T. Kuo, C. Y. Lu et al. // Neuroradiology. – 2004. – Vol.46(8). – P. 619–627.38.Crawford, F. W. Relationship of pre-surgery metabolic and physiological MRimaging parameters to survival for patients with untreated GBM / F. W. Crawford,100I.
S. Khayal, C. McGue et al. // Journal of Neuro-oncology. – 2009. – Vol. 91. – P.337–51.39.Croteau, D. Correlation between magnetic resonance spectroscopy imagingand image-guided biopsies: semiquantitative and qualitative histopathologicalanalyses of patients with untreated glioma. / D. Croteau, L. Scarpace, D. Hearshenet al.
// Neurosurgery. – 2001. – Vol. 49(4). – P. 823–829.40.Danielsen, E. Magnetic resonance spectroscopy diagnosis of neurologicaldiseases / E. Danielsen, B. Ross // New York: Marcel-Dekker. - 1999. – P. 15541.Davies, N. P. Identification and characterisation of childhood cerebellartumours by in vivo proton MRS / N. P. Davies, M.
Wilson, L. M. Harris et al. //NMR in Biomedicine. – 2008. Vol. 21. – P. 908–918.42.De Edelenyi, F. S. A new approach for analyzing proton magnetic resonancespectroscopic images of brain tumors: nosologic images / F. S. De Edelenyi, C.Rubin, F. Esteve et al. // Nat Med. – 2000. – Vol. 6(11). – P. 1287–1289.43.De Stefano, N. Guidelines for using proton MR spectroscopy in multicenterclinical MS studies / N.
De Stefano, M. Filippi, D. Miller et al. // Neurology. – 2007- Vol. 69(20). – P. 1942–1952.44.Demir, M. K. Single voxel proton MR spectroscopy findings of typical andatypical intracranial meningiomas / M. K. Demir, A. C. Iplikcioglu, A. Dincer, etal. // Eur J Radiol. – 2006. Vol. 60(1). – P. 48–55.45.Dhermain, F. Microvascular leakage and contrast enhancement as prognosticfactors for recurrence in unfavorable low-grade gliomas / F. Dhermain, G.
Saliou,F. Parker et al.// Journal of Neuro-oncology. – 2010. – Vol. 97. – P. 81–88.46.Duijn, J. H. Human brain infarction: proton MR spectroscopy / J. H. Duijn,G. B. Matson, A. A. Maudsley at al. // Radiology. – 1992. – Vol. 183. – P. 711-71847.Engelhard, H. H. Oligodendroglioma: pathology and molecular biology / H.H.
Engelhard, A. Stelea, E. J. Cochran // Surg Neurol. – 2002. – Vol. 58. - P. 111–11710148.Ernst, T. Frontotemporal dementia and early Alzheimer disease: differentiation withfrontal lobe H-l MR spectroscopy / T. Ernst, L. Chang, R. Melchor // Radiology. – 1997. –Vol. 203. – P. 829-836.49.Fan, G. In vivo single-voxel proton MR spectroscopy in the differentiation ofhigh-grade gliomas and solitary metastases / G. Fan, B.
Sun, Z. Wu et al. // ClinRadiol. – 2004. – Vol. 59(1). – P. 77–85.50.Fan, G. Comments and controversies: magnetic resonance spectroscopy andgliomas // Cancer Imaging: The Official Publication of the International CancerImaging Society. – 2006. – Vol. 6. – P. 113–115.51.Federico, F. Prognostic value of proton magnetic resonance spectroscopy inischemic stroke / F. Federico, I. L. Simone, V. Lucivero et al. // Arch Neurol. - 1998.– Vol. 55.
– P. 489-494.52.Felber, S. R. Combined magnetic resonance imaging and proton magneticresonance spectroscopy of patients with acute stroke / S. R. Felber, F. T. Aichner,R. Sauter et al. // Stroke. – 1992. – Vol. 23. – P. 1106- 1110.53.Felsberg, G.J. Gliomatosis cerebri: radiologic-pathologic correlation / G. J.Felsberg, S.
A. Silver, M. T. Brown et al. // AJNR Am J Neuroradiol. – 1994. – Vol.15. – P. 1745–1751.54.Fenstermacher, M. J.Serial proton magnetic resonance spectroscopy ofischemic brain injury in humans /, M. J. Fenstermacher, P. A. Narayana // InvestRadiol. – 1990. – Vol. 25. – P. 1034- 1039.55.Ford, C. C. Multivoxel 1 H-MRS of stroke / C. C. Ford, R.
H. Griffey, N. A.Matwiyoff et al. // Neurology. – 1992. – Vol. 42. – P. 1408- 1412.56.Frahm, J. Localized high-resolution proton NMR spectroscopy usingstimulated echoes: initial applications to human brain in vivo / J. Frahm, H. Bruhn,M. L. Gyngel et al. // Magn Reson Med. – 1989. – Vol. 9(1). – P. 79–93.57.Furnari, F. B. Malignant astrocytic glioma: genetics, biology, and paths totreatment / F. B.
Furnari, T. Fenton, R. M. Bachoo et al // Genes & Development. 2007. – Vol. 21. – P. 2683–2710.10258.Ganslandt, O. Proton magnetic resonance spectroscopic imaging integratedinto image-guided surgery: correlation to standard magnetic resonance imaging andtumor cell density / O. Ganslandt, A.
Stadlbauer, R. Fahlbusch et al. // Neurosurgery.– 2005. – Vol. 56. – P. 291–298.59.Giangaspero,F.Comparisonofcytologiccompositionwithmicrofluorometric DNA analysis of the glioblastoma multiforme and anaplasticastrocytoma / F. Giangaspero, P. Chieco, G. Lisignoli et al. // Cancer. – 1987. – Vol.60. – P. 59–65.60.Gideon, P.Earlytimecourseof N-acetylaspartate,creatineandphosphocreatine, and compounds containing choline in the brain after acute stroke /P. Gideon, O.S. Henriksen, B. Sperling et al.
// Stroke. – 1992. – Vol. 23. – P.1566- 1572.61.Gideon, P. Long-term follow up of cerebral infarction patients with protonmagnetic resonance spectroscopy / P. S. Gideon, B. Sperling, P. O. Arlien-Soborg //Stroke. – 1994. – Vol. 25. – P. 967- 973.62.Giese, A. Cost of migration: invasion of malignant gliomas and implicationsfor treatment / A. Giese, R. Bjerkvig, M. E. Berens et al // Journal of ClinicalOncology: Official Journal of the American Society of Clinical Oncology.
– 2003.– Vol. 21. – P. 1624–1636.63.Gill, S. S. Proton MR spectroscopy of intracranial tumours: in vivo and invitro studies / S. S. Gill, D. G. Thomas, N. Van Bruggen et al. // J Comput AssistTomogr. – 1990. – Vol. 14(4). – P. 497–504.64.Gillard, J. H. Proton MR spectroscopy in acute middle cerebral artery stroke/ J. H. Gillard, P. B. Barker, P. C. van Zijl et al. // AJNR Am J Neuroradiol. - 1996.– Vol. 17. – P. 873- 886.65.Goebell, E. Disarrangement of fiber tracts and decline of neuronal densitycorrelate in glioma patients — a combined diffusion tensor imaging and 1H-MRspectroscopy study / E. Goebell, J.
Fiehler, X. Q. Ding et al. // AJNR: AmericanJournal of Neuroradiology. – 2006. – Vol. 27. – P. 1426–1431.10366.Gonzalez-Bonet, L. G. Stereotactic biopsy versus spectroscopy in cases ofgliomas with a high degree of malignancy. A review of the literature // Revista deneurologia. – 2008. – Vol. 47. – P. 310–314.67.Graham, G. D. Temporal variation of cerebral metabolites after human stroke:a proton magnetic resonance spectroscopy study / G. D. Graham, A.
M. Blamire, D.L. Rothman et al. // Stroke. – 1993. – Vol. 24. – P. 1891- 1896.68.Grand, S. In vivo sup 1 H MRS of brain abscesses versus necrotic brain tumors/ S. Grand, E. Lai, F. Esteve et al. // Neurology. – 1996. – Vol. 47(3). – P.
846-848.69.Gupta, R. K. Relationships between choline magnetic resonancespectroscopy, apparent diffusion coefficient and quantitative histopathology inhuman glioma / R. K. Gupta, T. F. Cloughesy, U. Sinha et al. // J Neurooncol. –2000. – Vol. 50(3). – P. 215–226.70.Hall, W. A. The safety and efficacy of stereotactic biopsy for intracraniallesions // Cancer. – 1998. – Vol. 82. – P. 1749–1755.71.Hanstock. C. C.
Spatially localized 1H NMR spectra of metabolites in thehuman brain / C. C. Hanstock, D.L. Rothman, J. W. Prichard et al. // Proc Natl AcadSci. – 1988. – Vol. 85(6). – P. 1821–1825.72.Harris, L. M. Magnetic resonance spectroscopy in the assessment of pilocyticastrocytomas / L. M. Harris, N.
P. Davies, L. Macpherson et al. // European Journalof Cancer. – 2008. – Vol. 44. – P. 2640–2647.73.Hattingen, E. (1)H MRSI and progression-free survival in patients with WHOgrades II and III gliomas / E. Hattingen, O. Delic, K. Franz et al. // NeurologicalResearch. – 2010. – Vol. 32. – P. 593–602.74.Hattingen, E. Prognostic value of choline and creatine in WHO grade IIgliomas / E. Hattingen, P. Raab, K. Franz et al. // Neuroradiology. – 2008. – Vol.50. – P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
